Murine and Chinese cobra venom‑derived nerve growth factor stimulate chondrogenic differentiation of BMSCs in vitro: A comparative study Corrigendum in /10.3892/mmr.2021.12444

Miao,Zhikang; Lu,Zhenhui; Luo,Shixing; Lei,Danqing; He,Yi; Wu,Huayu; Zhao,Jinmin; Zheng,Li

doi:10.3892/mmr.2018.9307

Murine and Chinese cobra venom‑derived nerve growth factor stimulate chondrogenic differentiation of BMSCs in vitro: A comparative study

Corrigendum in: /10.3892/mmr.2021.12444

Authors:
- Zhikang Miao
- Zhenhui Lu
- Shixing Luo
- Danqing Lei
- Yi He
- Huayu Wu
- Jinmin Zhao
- Li Zheng
View Affiliations

Affiliations: Guangxi Engineering Center in Biomedical Material for Tissue and Organ Regeneration, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China, Department of Orthopedics, Ninth Affiliated Hospital of Guangxi Medical University, Beihai 536000, P.R. China, Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China, Department of Cell Biology and Genetics, School of Premedical Sciences, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China
Published online on: July 23, 2018 https://doi.org/10.3892/mmr.2018.9307
Pages: 3341-3349
Copyright: © Miao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mesenchymal stem cell (MSC)‑based therapy has been commonly used in cartilage reconstruction, due to its self‑renewing ability and multi‑differentiation potential. Nerve growth factor (NGF) from cobra venom has been reported to regulate chondrogenesis of bone‑derived MSCs (BMSCs) and chondrocyte metabolism. Therefore, the present study aimed to determine whether other sources of NGF behave in the same manner as NGF from natural venom. The present study compared the effects of NGF from two sources, the commercially purchased recombinant murine β‑NGF (mNGF) and cobra venom‑derived NGF (cvNGF), on chondrogenesis of BMSCs by performing hematoxylin and eosin and fluorescein diacetate/propidium iodide staining, DNA and glycosaminoglycan quantization and reverse transcription‑quantitative polymerase chain reaction to investigate cell morphology, viability, proliferation, glycosaminoglycan synthesis and cartilage‑specific gene expression. The results demonstrated that cvNGF significantly accelerated cell proliferation and upregulated the expression of cartilage‑specific genes, including aggrecan, SRY‑box 9 and collagen type II α1 chain. Conversely, cvNGF reduced the expression levels of collagen type I α1 chain (a fibrocartilage marker), runt‑related transcription factor 2 and enolase 2 compared with in the mNGF and control groups. In addition, Chinese cobra venom, which is the main resource of cvNGF, is abundant and inexpensive, thus greatly decreasing the cost. In conclusion, the present study demonstrated that cvNGF may be considered a potential growth factor for inducing chondrogenic differentiation of BMSCs.

View Figures

View References

1	Risbud MV and Sittinger M: Tissue engineering: Advances in in vitro cartilage generation. Trends Biotechnol. 20:351–356. 2002. View Article : Google Scholar : PubMed/NCBI
2	Wu YN, Yang Z, Hui JH, Ouyang HW and Lee EH: Cartilaginous ECM component-modification of the micro-bead culture system for chondrogenic differentiation of mesenchymal stem cells. Biomaterials. 28:4056–4067. 2007. View Article : Google Scholar : PubMed/NCBI
3	Nakasa T and Ochi M: Cell based therapy for articular cartilage injury. Clin Calcium. 21:890–895. 2011.(In Japanese). PubMed/NCBI
4	Caldwell KL and Wang J: Cell-based articular cartilage repair: The link between development and regeneration. Osteoarthritis Cartilage. 23:351–362. 2015. View Article : Google Scholar : PubMed/NCBI
5	Jiang T, Xu G, Wang Q, Yang L, Zheng L, Zhao J and Zhang X: In vitro expansion impaired the stemness of early passage mesenchymal stem cells for treatment of cartilage defects. Cell Death Dis. 8:e28512017. View Article : Google Scholar : PubMed/NCBI
6	Szychlinska MA, Stoddart MJ, D'Amora U, Ambrosio L, Alini M and Musumeci G: Mesenchymal stem cell-based cartilage regeneration approach and cell senescence: Can we manipulate cell aging and function? Tissue Eng Part B Rev. 23:529–539. 2017. View Article : Google Scholar : PubMed/NCBI
7	Raghunath J, Salacinski HJ, Sales KM, Butler PE and Seifalian AM: Advancing cartilage tissue engineering: The application of stem cell technology. Curr Opin Biotechnol. 16:503–509. 2005. View Article : Google Scholar : PubMed/NCBI
8	Lu Z, Lei D, Jiang T, Yang L, Zheng L and Zhao J: Nerve growth factor from Chinese cobra venom stimulates chondrogenic differentiation of mesenchymal stem cells. Cell Death Dis. 8:e28012017. View Article : Google Scholar : PubMed/NCBI
9	van Beuningen HM, Glansbeek HL, van der Kraan PM and van den Berg WB: Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage. 6:306–317. 1998. View Article : Google Scholar : PubMed/NCBI
10	Bakker AC, van de Loo FA, van Beuningen HM, Sime P, van Lent PL, van der Kraan PM, Richards CD and van den Berg WB: Overexpression of active TGF-beta-1 in the murine knee joint: Evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarthritis Cartilage. 9:128–136. 2001. View Article : Google Scholar : PubMed/NCBI
11	Davidson Blaney EN, Vitters EL, van Beuningen HM, van de Loo FA, van den Berg WB and van der Kraan PM: Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: Limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation. Arthritis Rheum. 56:4065–4073. 2007. View Article : Google Scholar : PubMed/NCBI
12	Li C, Jiang J, Zheng Z, Lee KS, Zhou Y, Chen E, Culiat CT, Qiao Y, Chen X, Ting K, et al: Neural EGFL-like 1 is a downstream regulator of runt-related transcription factor 2 in chondrogenic differentiation and maturation. Am J Pathol. 187:963–972. 2017. View Article : Google Scholar : PubMed/NCBI
13	Grässel SG: The role of peripheral nerve fibers and their neurotransmitters in cartilage and bone physiology and pathophysiology. Arthritis Res Ther. 16:4852014. View Article : Google Scholar : PubMed/NCBI
14	Nojiri Y, Takeda S, Enomoto M, Nishitsuji H, Masuda T, Sotome S and Shinomiya K: Co-overexpression of GDNF and GFRalpha1 induces neural differentiation in neural progenitor cells in comparison to bone marrow stromal cells. J Med Dent Sci. 55:121–128. 2008.PubMed/NCBI
15	Lipps BV: Detection of nerve growth factor (NGF) in venoms from diverse source: Isolation and characterization of NGF from the venom of honey bee (Apis melifera). J Nat Toxins. 9:13–19. 2000.PubMed/NCBI
16	Lipps BV: Isolation of nerve growth factor (NGF) from human body fluids; saliva, serum and urine: Comparison between cobra venom and cobra serum NGF. J Nat Toxins. 9:349–356. 2000.PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Caplan AI: Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 213:341–347. 2007. View Article : Google Scholar : PubMed/NCBI
19	Tew SR, Li Y, Pothacharoen P, Tweats LM, Hawkins RE and Hardingham TE: Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. Osteoarthritis Cartilage. 13:80–89. 2005. View Article : Google Scholar : PubMed/NCBI
20	Uebersax L, Merkle HP and Meinel L: Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J Control Release. 127:12–21. 2008. View Article : Google Scholar : PubMed/NCBI
21	Marshall OJ and Harley VR: Molecular mechanisms of SOX9 action. Mol Genet Metab. 71:455–462. 2000. View Article : Google Scholar : PubMed/NCBI
22	Tew SR and Clegg PD: Analysis of post transcriptional regulation of SOX9 mRNA during in vitro chondrogenesis. Tissue Eng Part A. 17:1801–1807. 2011. View Article : Google Scholar : PubMed/NCBI
23	Robinson D, Ash H, Yayon A, Nevo Z and Aviezer D: Characteristics of cartilage biopsies used for autologous chondrocytes transplantation. Cell Transplant. 10:203–208. 2001.PubMed/NCBI
24	Zhang W, Chen J, Tao J, Jiang Y, Hu C, Huang L, Ji J and Ouyang HW: The use of type 1 collagen scaffold containing stromal cell-derived factor-1 to create a matrix environment conducive to partial-thickness cartilage defects repair. Biomaterials. 34:713–723. 2013. View Article : Google Scholar : PubMed/NCBI
25	Liu CF, Samsa WE, Zhou G and Lefebvre V: Transcriptional control of chondrocyte specification and differentiation. Semin Cell Dev Biol. 62:34–49. 2017. View Article : Google Scholar : PubMed/NCBI
26	Yoshii SR, Kuma A and Mizushima N: Transgenic rescue of Atg5-null mice from neonatal lethality with neuron-specific expression of ATG5: Systemic analysis of adult Atg5-deficient mice. Autophagy. 13:763–764. 2017. View Article : Google Scholar : PubMed/NCBI